ArticleBMC microbiology2026
An exploratory 12-week pilot study of gut microbiota and body-weight patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in Wistar rats.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSodium nitrite (E250) is a widely used additive in processed meat products and has been reported to disrupt the gut microbiota and exert carcinogenic effects via N-nitroso compounds. This exploratory pilot study examined body-weight and longitudinal gut-microbiota patterns during sodium nitrite exposure and Lactobacillus plantarum 299v supplementation in adolescent Wistar rats.
methodsSixty-four adolescent Wistar rats were allocated to Control, sodium nitrite (SN), Lactobacillus plantarum 299v (LP), or combined SN + LP groups for 12 weeks. Body weight was assessed in the full cohort. The exploratory microbiota component comprised 48 serial fecal samples from eight selected rats, with one male and one female from each treatment group. V3-V4 16S rRNA amplicons were sequenced on an Illumina iSeq 100 using a 2 × 150-bp paired-end configuration. Read 1 (R1) sequences were processed using the single-end DADA2 workflow, and microbiota profiles were analyzed descriptively.
resultsBody-weight trajectories varied across groups and sexes in the full cohort. The descriptive relative-abundance profiles varied across sampling times. The sodium nitrite profile showed higher relative Proteobacteria abundance at several post-baseline time points, while longitudinal ordination trajectories overlapped substantially.
conclusionsThe exploratory findings describe patterns across sampling times but do not establish group-level treatment effects or probiotic attenuation of nitrite-associated changes. Confirmation in adequately powered studies with independent cage-level replication is required. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
42919129What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.